Scientist I, Nanoparticle Formulation and Process Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

GenEdit · 3 weeks ago

Scientist I, Nanoparticle Formulation and Process Development

GenEdit is an early-stage company developing a novel delivery platform for genetic medicines. The role involves supporting the development of genetic medicines through nanoparticle formulation in a lab setting, with responsibilities including executing and optimizing analytical techniques and maintaining detailed lab records.

BiotechnologyGeneticsPharmaceuticalTherapeutics
badNo H1Bnote

Responsibilities

Support the development of genetic medicines utilizing GenEdit’s proprietary hydrophilic nanoparticle (HNP) platform
Work full-time in our wet labs to support nanoparticle formulation activities
Execute at a high level in the lab
Keep detailed lab records
Execute, optimize, and develop analytical techniques
Cooperate efficiently with other technicians and scientists

Qualification

Nanoparticle formulationAnalytical characterizationProcess developmentMRNA encapsulationLight scattering techniquesMolecular biology techniquesExperimental designTechnical troubleshootingCommunication skillsOrganizational skills

Required

PhD (or BS/MS with significant experience) in nanoparticle sciences and formulation
3+ years of relevant hands-on lab experience, ideally in an industry setting
Required: expertise in nanoparticle formulation and related analytical characterization: optimization of mRNA and small molecule encapsulation mixing methods (IJM, microfluidics), light scattering and zeta potential (DLS, MALS), quantitative fluorescence assays (RiboGreen, fluorescamine)
Capable of independent experimental design, execution, and technical trouble shooting
Ability to efficiently execute in the lab, develop standard operating procedures with precise reproducibility, and maintain detailed electronic lab notebook records
Excellent communication, presentation, and organizational skills
Work authorization in the US is required

Preferred

Highly preferred: nanoparticle scale-up manufacturing and process development including purification and concentration methods (TFF, UF/DF, sterile filtration, analytical HPLC) and standard molecular and cell biology techniques including UV-Vis, gel electrophoresis, protein expression characterization (western blot, ELISA, flow cytometry, FlowJo) and transfection of mammalian tissue culture

Company

GenEdit

twittertwitter
company-logo
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Funding

Current Stage
Early Stage
Total Funding
$67.72M
Key Investors
Qiming Venture PartnersEli LillyNational Science Foundation
2024-01-23Series A· $24M
2021-11-01Angel· $9M
2021-09-23Series A· $26M

Leadership Team

leader-logo
Hyo Min Park
Co-Founder & Chief Operating Officer
linkedin
leader-logo
Timothy Fong
CTO
linkedin
Company data provided by crunchbase